David Nathan, MD
Dermatology · Avon, INNPI 1619963998
Payments from drug & device makers
Across 230 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$651
- Pfizer$635
- Regeneron Healthcare Solutions, Inc.$393
- Amgen$267
- E.r. Squibb & Sons, L.L.C.$158
- plus $922 from 16 others
What the payments were for
- Food & beverage$3,95993%
- Education$3127%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,245 |
| Johnson & Johnson | 31 | $651 |
| Pfizer | 39 | $635 |
| Regeneron Healthcare Solutions, Inc. | 15 | $393 |
| Amgen | 16 | $267 |
| E.r. Squibb & Sons, L.L.C. | 10 | $158 |
| Galderma Laboratories, L.p. | 4 | $136 |
| Novartis | 6 | $113 |
| Sun Pharmaceutical Industries Inc. | 6 | $108 |
| Janssen Scientific Affairs, LLC | 3 | $91 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $86 |
| UCB, Inc. | 4 | $83 |
| LEO Pharma Inc. | 4 | $67 |
| Incyte Corporation | 3 | $62 |
| Verrica Pharmaceuticals Inc. | 2 | $43 |
| Cipher Pharmaceuticals US LLC | 1 | $27 |
| Convatec Inc. | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $23 |
| AstraZeneca | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| LNHC, Inc | 1 | $14 |
| Organon | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$121
How this compares
$4,270 in reported general payments places this provider in the 45th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 378 | $8,522 |
| Betamethasone Dipropionate | 180 | $7,852 |
| Triamcinolone Acetonide | 343 | $5,570 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 90 | $2,372 |
| Minocycline Hcl | 42 | $2,197 |
| Metronidazole | 32 | $1,742 |
| Ketoconazole | 100 | $1,687 |
| Hydroxyzine Hcl | 90 | $1,629 |
| Fluorouracil | 18 | $1,049 |
| Prednisone | 278 | $903 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $901 |
| Minoxidil | 47 | $824 |
| Doxycycline Hyclate | 16 | $809 |
| Clobetasol Propionate | 18 | $774 |
| Terbinafine Hcl | 57 | $751 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Avon
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Holly Hake HarrisSouth Bend$3.4M
- Megan LandisCorydon$2.8M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
- Vassilios DimitropoulosMichigan City$1.8M
- Christopher ObeimeIndianapolis$907K
- Megan VissingNew Albany$884K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.